World News and Views :: Top of the News
Shasun Ties with Merck & Co.
7:52 AM MST | February 27, 2008 | Deepti Ramesh
Shasun Chemicals & Drugs (Chennai, India), a pharmaceutical company, says it has entered into an active pharma ingredient (API) technology licensing agreement with Merck & Co. Inc. (Whitehouse Station, NJ). Under the non-exclusive agreement, Shasun will provide Merck with the use of its proprietary cross-coupling copper technology (known as Buchwald technology) to manufacture and commercialize APIs. “This is an important milestone for Shasun in making this technology widely accessible and paving the way for further collaborations,” says...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee